Viral drug resistance through 48 weeks, in a phase 2b, randomized, controlled trial of the HIV-1 attachment inhibitor prodrug, fostemsavir
Journal of Acquired Immune Deficiency Syndromes | Feb 15, 2018
Rapid serological tests ineffectively screen for HIV exposure in HIV-positive infants
Journal of Acquired Immune Deficiency Syndromes | Feb 15, 2018
Cross-reactivity and tolerability of cephalosporins in patients with IgE-mediated hypersensitivity to penicillins
The Journal of Allergy and Clinical Immunology: In Practice | Feb 14, 2018
Most read this week